Join us in breaking the barriers.

We are a passionate and driven international team of dynamic innovators transforming the lives of tricuspid regurgitation patients.

Headquartered in Germany, Coramaze is an international company with a dedicated R&D center in Israel and operations across the United States and Europe. Our team brings together talent from over six nationalities, united by a shared mission to transform tricuspid care.

Coramaze lab
Coramaze office

Shape the future of cardiovascular care

Be part of the team bringing life-changing innovation to patients with tricuspid regurgitation.

Your work goes beyond the lab—you will directly contribute to solving one of cardiology’s most overlooked challenges with a device designed to save and improve lives.

Collaborate with leading experts

Join an elite, international team of medtech innovators, clinicians, and engineers.

From development to clinical execution, you will work side by side with leading minds in cardiovascular medicine and device engineering—building something truly first-in-class.

Accelerate your learning curve

Grow faster by working at the cutting edge of structural heart innovation

Whether in R&D, clinical, or operations, we offer the rare opportunity to take ownership, learn across disciplines, and grow within a fast-paced, purpose-driven environment.

Apply to advance Tripair

Ready to make a real impact? Join us in building the future of cardiovascular innovation.

Quality Assurance Associate
VP R&D
Senior Manager Clinical Operations
[ 01 - 03 ]
Sapir
Quality Assurance Associate
Shai
VP R&D
Lucia
Senior Manager Clinical Operations
“Being part of the QA team at Coramaze means upholding the highest standards, every step of the way. I'm proud to work alongside a team committed to delivering a safe and meaningful solution for patients with tricuspid regurgitation. ”
“Being part of the Tripair development team means tackling one of the biggest challenges in structural heart care—every idea, prototype, and decision directly shapes a solution that could transform treatment for tricuspid regurgitation.”
“At Coramaze, you are not just building a device—you are shaping the future of tricuspid care alongside brilliant, driven people who challenge and inspire you every day.”